Our response to COVID-19
 

With the COVID-19 pandemic escalating, President and chief executive officer of Novo Nordisk, Lars Fruergaard Jørgensen makes the case for resilience, collective action and learning from past experience in the face of an unprecedented challenge.

Our commitment to patients, partners and our employees

We offer 0 job opportunities


Turning scientific ideas into medicines

From formulating protein molecules in a tablet to stem cell research, our scientists are always striving for the next breakthrough。

Read more about our work in the lab

 


Making our medicines accessible and affordable

For many people with diabetes, insulin is an essential, life-saving medicine。 It’s our ambition that everyone who needs insulin has access to it at prices they can afford。

Read more about our access and affordability programmes


Preventing the rise of type 2 diabetes

The huge rise in type 2 diabetes around the world is catastrophic. Uncontrolled, this rise is not sustainable for anyone – people, health systems, businesses or economies。 Bending the curve on diabetes is therefore crucial to all of us。 

Read about our efforts to prevent type 2 diabetes

福建快3 江苏快3 吉林快3 贵州快3 北京赛车PK10计划 海南4+1 一品彩票开户 湖北快3 江西快3 广西快3